Suchergebnisse - "Romani, Chiara"

PubPharm (93)

21

Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer

enthalten in: International journal of cancer | 2020

von Benvenuto, G. | Todeschini, P. | Paracchini, L. | +22

22

Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients

enthalten in: Frontiers in oncology | 2020

von Bignotti, E. | Zanotti, L. | Todeschini, P. | +8

23

Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients

enthalten in: Frontiers in oncology | 2020

von Romani, C. | Zizioli, V. | Silvestri, M. | +16

24

Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2019

von Zammataro, L. | Lopez, S. | Bellone, S. | +42

25

FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients

enthalten in: British journal of cancer | 2019

von Tassi, R. | Gambino, A. | Ardighieri, L. | +12

26

Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2019

von Li, C. | Bonazzoli, E. | Bellone, S. | +36

ErratumIn: Proc Natl Acad Sci U S A. 2019 Mar 19;116(12):5829. - PMID 30858325

27

Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitor

Erschienen: 2019

von Li, C. | Bonazzoli, E. | Bellone, S. | +36

28

Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy

Erschienen: 2019

von Zammataro, L. | Lopez, S. | Bellone, S. | +42

29

Claudin3 is localized outside the tight junctions in human carcinomas

enthalten in: Oncotarget | 2018

von Corsini, M. | Ravaggi, A. | Odicino, F. | +5

30

Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer

enthalten in: The Laryngoscope | 2017

von Zanotti, L. | Paderno, A. | Piazza, C. | +8

CommentIn: Laryngorhinootologie. 2018 May;97(5):302-303. - PMID 29719888